{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:51:58Z","timestamp":1792806718542,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR18C001208"],"award-info":[{"award-number":["HR18C001208"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-202400437692"],"award-info":[{"award-number":["RS-202400437692"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00245081"],"award-info":[{"award-number":["RS-2023-00245081"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metformin is widely used as a first-line therapy for type 2 diabetes mellitus. However, the molecular mechanisms by which it modulates intestinal glucose metabolism remain incompletely defined. Here metformin was orally administered to male C57BL\/6 mice, followed by intraperitoneal glucose tolerance testing and fluorine-18 fluorodeoxyglucose tracing to evaluate glucose homeostasis. To investigate changes in intestinal glucose metabolism, IEC6 and Caco-2 cell lines were used for in vitro analysis, with organoid experiments conducted for further validation. qRT-PCR, western blotting, flow cytometry and immunohistochemistry were performed to elucidate the effects of metformin on glucose metabolism pathways. Metformin enhanced glucose uptake and excretion in the distal intestine, particularly in the ileum and colon. Mechanistically, metformin upregulated the expression and membrane localization of glucose transporter 1 (GLUT1) by downregulating thioredoxin-interacting protein (TXNIP) expression. Consistently, intestinal-specific overexpression of TXNIP abolished metformin-induced improvements in glucose tolerance, while pharmacological inhibition of GLUT1 similarly negated metformin\u2019s glucose-lowering effects. Our findings identified intestinal glucose excretion, mediated through the intestinal TXNIP\u2013GLUT1 regulatory axis, as a previously unrecognized contributor to metformin\u2019s glucoregulatory action. These results highlight a novel intestinal mechanism underlying metformin\u2019s efficacy and provide insights for potential therapeutic strategies beyond traditional glucose regulation.<\/jats:p>","DOI":"10.1038\/s12276-025-01518-w","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T10:27:10Z","timestamp":1754476030000},"page":"1775-1788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel mechanism whereby metformin improves glucose homeostasis: TXNIP\u2013GLUT1 axis modulation enhances intestinal glucotonic effects"],"prefix":"10.1038","volume":"57","author":[{"given":"Chan Woo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5001-5875","authenticated-orcid":false,"given":"Jung Ho","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ju","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Kook","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-5567","authenticated-orcid":false,"given":"Sungsoon","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-9630","authenticated-orcid":false,"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"1518_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M. & Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953\u2013966 (2014).","journal-title":"Cell Metab."},{"key":"1518_CR2","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","volume":"60","author":"CJ Bailey","year":"2017","unstructured":"Bailey, C. J. Metformin: historical overview. Diabetologia 60, 1566\u20131576 (2017).","journal-title":"Diabetologia"},{"key":"1518_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Metformin: update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460\u2013476 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"Pt 3","key":"1518_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 348(Pt 3), 607\u2013614 (2000).","journal-title":"Biochem J."},{"key":"1518_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest 108, 1167\u20131174 (2001).","journal-title":"J. Clin. Invest"},{"key":"1518_CR6","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","volume":"51","author":"N Musi","year":"2002","unstructured":"Musi, N. et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074\u20132081 (2002).","journal-title":"Diabetes"},{"key":"1518_CR7","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642\u20131646 (2005).","journal-title":"Science"},{"key":"1518_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin, N. R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727\u2013735 (2014).","journal-title":"Gut"},{"key":"1518_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42531-0","volume":"9","author":"O Horakova","year":"2019","unstructured":"Horakova, O. et al. Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Sci. Rep. 9, 6156 (2019).","journal-title":"Sci. Rep."},{"key":"1518_CR10","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cmet.2019.08.009","volume":"30","author":"Y Song","year":"2019","unstructured":"Song, Y. et al. Gut-proglucagon-derived peptides are essential for regulating glucose homeostasis in mice. Cell Metab. 30, 976\u2013986.e973 (2019).","journal-title":"Cell Metab."},{"key":"1518_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/5584_2020_496","volume":"1307","author":"DB Maselli","year":"2021","unstructured":"Maselli, D. B. & Camilleri, M. Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity. Adv. Exp. Med Biol. 1307, 171\u2013192 (2021).","journal-title":"Adv. Exp. Med Biol."},{"key":"1518_CR12","doi-asserted-by":"crossref","unstructured":"Portincasa, P. et al. Gut microbiota and short chain fatty acids: implications in glucose homeostasis. Int. J. Mol. Sci. 23, 1105 (2022).","DOI":"10.3390\/ijms23031105"},{"key":"1518_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s42255-023-00744-8","volume":"5","author":"P Wang","year":"2023","unstructured":"Wang, P. et al. Total parenteral nutrition impairs glucose metabolism by modifying the gut microbiome. Nat. Metab. 5, 331\u2013348 (2023).","journal-title":"Nat. Metab."},{"key":"1518_CR14","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.cmet.2022.09.024","volume":"34","author":"JH Shin","year":"2022","unstructured":"Shin, J. H. et al. The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function. Cell Metab. 34, 1765\u20131778.e1766 (2022).","journal-title":"Cell Metab."},{"key":"1518_CR15","doi-asserted-by":"publisher","first-page":"e0249594","DOI":"10.1371\/journal.pone.0249594","volume":"16","author":"DM Zake","year":"2021","unstructured":"Zake, D. M. et al. Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues. PLoS ONE 16, e0249594 (2021).","journal-title":"PLoS ONE"},{"key":"1518_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","volume":"34","author":"M Mueckler","year":"2013","unstructured":"Mueckler, M. & Thorens, B. The SLC2 (GLUT) family of membrane transporters. Mol. Asp. Med 34, 121\u2013138 (2013).","journal-title":"Mol. Asp. Med"},{"key":"1518_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature13306","volume":"510","author":"D Deng","year":"2014","unstructured":"Deng, D. et al. Crystal structure of the human glucose transporter GLUT1. Nature 510, 121\u2013125 (2014).","journal-title":"Nature"},{"key":"1518_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00424-020-02439-5","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell, H. Glucose transporters in the small intestine in health and disease. Pflug. Arch. 472, 1207\u20131248 (2020).","journal-title":"Pflug. Arch."},{"key":"1518_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"EH Choi","year":"2023","unstructured":"Choi, E. H. & Park, S. J. TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target. Exp. Mol. Med 55, 1348\u20131356 (2023).","journal-title":"Exp. Mol. Med"},{"key":"1518_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2337\/db07-0715","volume":"57","author":"J Chen","year":"2008","unstructured":"Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J. & Shalev, A. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 57, 938\u2013944 (2008).","journal-title":"Diabetes"},{"key":"1518_CR21","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1371\/journal.pmed.0040158","volume":"4","author":"H Parikh","year":"2007","unstructured":"Parikh, H. et al. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 4, e158 (2007).","journal-title":"PLoS Med."},{"key":"1518_CR22","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1210\/en.2004-1378","volume":"146","author":"AH Minn","year":"2005","unstructured":"Minn, A. H., Hafele, C. & Shalev, A. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 146, 2397\u20132405 (2005).","journal-title":"Endocrinology"},{"key":"1518_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2021.183757","volume":"1863","author":"H Dykstra","year":"2021","unstructured":"Dykstra, H. et al. TXNIP interaction with GLUT1 depends on PI(4,5)P(2). Biochim Biophys. Acta Biomembr. 1863, 183757 (2021).","journal-title":"Biochim Biophys. Acta Biomembr."},{"key":"1518_CR24","doi-asserted-by":"publisher","first-page":"106150","DOI":"10.1016\/j.isci.2023.106150","volume":"26","author":"SJ Qualls-Histed","year":"2023","unstructured":"Qualls-Histed, S. J., Nielsen, C. P. & MacGurn, J. A. Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin. iScience 26, 106150 (2023).","journal-title":"iScience"},{"key":"1518_CR25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc20-0093","volume":"43","author":"Y Morita","year":"2020","unstructured":"Morita, Y. et al. Enhanced release of glucose into the intraluminal space of the intestine associated with metformin treatment as revealed by [(18)F]fluorodeoxyglucose PET\u2013MRI. Diabetes Care 43, 1796\u20131802 (2020).","journal-title":"Diabetes Care"},{"key":"1518_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211933120","volume":"120","author":"N Tobar","year":"2023","unstructured":"Tobar, N. et al. Metformin acts in the gut and induces gut\u2013liver crosstalk. Proc. Natl Acad. Sci. USA 120, e2211933120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1518_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2337\/db16-1000","volume":"66","author":"CR Ku","year":"2017","unstructured":"Ku, C. R. et al. Intestinal glycolysis visualized by FDG PET\/CT correlates with glucose decrement after gastrectomy. Diabetes 66, 385\u2013391 (2017).","journal-title":"Diabetes"},{"key":"1518_CR28","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1136\/gutjnl-2020-321402","volume":"70","author":"IG Kwon","year":"2021","unstructured":"Kwon, I. G. et al. Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 70, 1847\u20131856 (2021).","journal-title":"Gut"},{"key":"1518_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.937394","volume":"13","author":"JH Oh","year":"2022","unstructured":"Oh, J. H. et al. Altered glucose metabolism and glucose transporters in systemic organs after bariatric surgery. Front. Endocrinol. 13, 937394 (2022).","journal-title":"Front. Endocrinol."},{"key":"1518_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cmet.2016.01.018","volume":"23","author":"G Baud","year":"2016","unstructured":"Baud, G. et al. Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake. Cell Metab. 23, 547\u2013553 (2016).","journal-title":"Cell Metab."},{"key":"1518_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106057","volume":"26","author":"L Zubiaga","year":"2023","unstructured":"Zubiaga, L. et al. Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes. iScience 26, 106057 (2023).","journal-title":"iScience"},{"key":"1518_CR32","doi-asserted-by":"publisher","first-page":"155743","DOI":"10.1016\/j.metabol.2023.155743","volume":"152","author":"Z Ke","year":"2024","unstructured":"Ke, Z., Lu, Z., Li, Q. & Tong, W. Intestinal glucose excretion: a potential mechanism for glycemic control. Metabolism 152, 155743 (2024).","journal-title":"Metabolism"},{"key":"1518_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00943-y","volume":"20","author":"C Bao","year":"2022","unstructured":"Bao, C., Zhu, S., Song, K. & He, C. HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways. Cell Commun. Signal 20, 132 (2022).","journal-title":"Cell Commun. Signal"},{"key":"1518_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0006-2952(95)02243-0","volume":"51","author":"S Lenzen","year":"1996","unstructured":"Lenzen, S., Lortz, S. & Tiedge, M. Effect of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats. Biochem Pharm. 51, 893\u2013896 (1996).","journal-title":"Biochem Pharm."},{"key":"1518_CR35","doi-asserted-by":"publisher","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","volume":"3","author":"DA Chan","year":"2011","unstructured":"Chan, D. A. et al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci. Transl. Med 3, 94ra70 (2011).","journal-title":"Sci. Transl. Med"},{"key":"1518_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.stemcr.2014.05.002","volume":"3","author":"KR Boheler","year":"2014","unstructured":"Boheler, K. R. et al. A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets. Stem Cell Rep. 3, 185\u2013203 (2014).","journal-title":"Stem Cell Rep."},{"key":"1518_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molcel.2017.05.020","volume":"67","author":"S Roy","year":"2017","unstructured":"Roy, S., Leidal, A. M., Ye, J., Ronen, S. M. & Debnath, J. Autophagy-dependent shuttling of TBC1D5 controls plasma membrane translocation of GLUT1 and glucose uptake. Mol. Cell 67, 84\u201395.e85 (2017).","journal-title":"Mol. Cell"},{"key":"1518_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.celrep.2017.10.053","volume":"21","author":"SR Shinde","year":"2017","unstructured":"Shinde, S. R. & Maddika, S. PTEN regulates glucose transporter recycling by impairing SNX27 retromer assembly. Cell Rep. 21, 1655\u20131666 (2017).","journal-title":"Cell Rep."},{"key":"1518_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cell.2018.08.017","volume":"175","author":"WJ Sullivan","year":"2018","unstructured":"Sullivan, W. J. et al. Extracellular matrix remodeling regulates glucose metabolism through TXNIP destabilization. Cell 175, 117\u2013132.e121 (2018).","journal-title":"Cell"},{"key":"1518_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5483\/BMBRep.2018.51.9.197","volume":"51","author":"HJ Lee","year":"2018","unstructured":"Lee, H. J. & Cha, J. Y. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism. BMB Rep. 51, 429\u2013436 (2018).","journal-title":"BMB Rep."},{"key":"1518_CR41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","volume":"10","author":"G Vial","year":"2019","unstructured":"Vial, G., Detaille, D. & Guigas, B. Role of mitochondria in the mechanism(s) of action of metformin. Front. Endocrinol. 10, 294 (2019).","journal-title":"Front. Endocrinol."},{"key":"1518_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cmet.2016.09.006","volume":"24","author":"DY Gui","year":"2016","unstructured":"Gui, D. Y. et al. Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin. Cell Metab. 24, 716\u2013727 (2016).","journal-title":"Cell Metab."},{"key":"1518_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81349-7","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Sci. Rep. 11, 2529 (2021).","journal-title":"Sci. Rep."},{"key":"1518_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148482","volume":"1817","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Nrf2\/HO-1 blocks TXNIP\/NLRP3 interaction via elimination of ROS in oxygen-glucose deprivation-induced neuronal necroptosis. Brain Res. 1817, 148482 (2023).","journal-title":"Brain Res."},{"key":"1518_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 (2008).","journal-title":"FASEB J."},{"key":"1518_CR46","doi-asserted-by":"crossref","unstructured":"Bahne, E. et al. Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight 3, e93936 (2018).","DOI":"10.1172\/jci.insight.93936"},{"key":"1518_CR47","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/s00125-020-05236-y","volume":"63","author":"CKL Cravalho","year":"2020","unstructured":"Cravalho, C. K. L. et al. Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes. Diabetologia 63, 2194\u20132204 (2020).","journal-title":"Diabetologia"},{"key":"1518_CR48","doi-asserted-by":"publisher","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","volume":"295","author":"S Andrikopoulos","year":"2008","unstructured":"Andrikopoulos, S., Blair, A. R., Deluca, N., Fam, B. C. & Proietto, J. Evaluating the glucose tolerance test in mice. Am. J. Physiol. Endocrinol. Metab. 295, E1323\u2013E1332 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1518_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101440","volume":"57","author":"L Small","year":"2022","unstructured":"Small, L. et al. Comparative analysis of oral and intraperitoneal glucose tolerance tests in mice. Mol. Metab. 57, 101440 (2022).","journal-title":"Mol. Metab."},{"key":"1518_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll, A. P. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 (2020).","journal-title":"Nature"},{"key":"1518_CR51","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1007\/s11033-023-08535-w","volume":"50","author":"B Sun","year":"2023","unstructured":"Sun, B., Chen, H., Xue, J., Li, P. & Fu, X. The role of GLUT2 in glucose metabolism in multiple organs and tissues. Mol. Biol. Rep. 50, 6963\u20136974 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"1518_CR52","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.3632","volume":"48","author":"K Zhou","year":"2016","unstructured":"Zhou, K. et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat. Genet. 48, 1055\u20131059 (2016).","journal-title":"Nat. Genet."},{"key":"1518_CR53","doi-asserted-by":"publisher","first-page":"E227","DOI":"10.1152\/ajpendo.90245.2008","volume":"295","author":"V Douard","year":"2008","unstructured":"Douard, V. & Ferraris, R. P. Regulation of the fructose transporter GLUT5 in health and disease. Am. J. Physiol. Endocrinol. Metab. 295, E227\u2013E237 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1518_CR54","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.tips.2018.07.006","volume":"39","author":"A Vancura","year":"2018","unstructured":"Vancura, A., Bu, P., Bhagwat, M., Zeng, J. & Vancurova, I. Metformin as an anticancer agent. Trends Pharm. Sci. 39, 867\u2013878 (2018).","journal-title":"Trends Pharm. Sci."},{"key":"1518_CR55","doi-asserted-by":"publisher","first-page":"117717","DOI":"10.1016\/j.lfs.2020.117717","volume":"254","author":"B Zhao","year":"2020","unstructured":"Zhao, B. et al. Anticancer mechanisms of metformin: a review of the current evidence. Life Sci. 254, 117717 (2020).","journal-title":"Life Sci."},{"key":"1518_CR56","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/DDDT.S409373","volume":"17","author":"S Dutta","year":"2023","unstructured":"Dutta, S. et al. Metformin: a review of potential mechanism and therapeutic utility beyond diabetes. Drug Des. Dev. Ther. 17, 1907\u20131932 (2023).","journal-title":"Drug Des. Dev. Ther."},{"key":"1518_CR57","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/CMAR.S200059","volume":"11","author":"P Saraei","year":"2019","unstructured":"Saraei, P., Asadi, I., Kakar, M. A. & Moradi-Kor, N. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag. Res. 11, 3295\u20133313 (2019).","journal-title":"Cancer Manag. Res."},{"key":"1518_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04263-8","volume":"21","author":"Y Hua","year":"2023","unstructured":"Hua, Y. et al. Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing. J. Transl. Med 21, 403 (2023).","journal-title":"J. Transl. Med"},{"key":"1518_CR59","doi-asserted-by":"publisher","first-page":"101945","DOI":"10.1016\/j.tranon.2024.101945","volume":"44","author":"L Zhu","year":"2024","unstructured":"Zhu, L., Yang, K., Ren, Z., Yin, D. & Zhou, Y. Metformin as anticancer agent and adjuvant in cancer combination therapy: current progress and future prospect. Transl. Oncol. 44, 101945 (2024).","journal-title":"Transl. Oncol."},{"key":"1518_CR60","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fendo.2018.00622","volume":"9","author":"T Higurashi","year":"2018","unstructured":"Higurashi, T. & Nakajima, A. Metformin and colorectal cancer. Front. Endocrinol. 9, 622 (2018).","journal-title":"Front. Endocrinol."},{"key":"1518_CR61","doi-asserted-by":"publisher","first-page":"111885","DOI":"10.1016\/j.mce.2023.111885","volume":"565","author":"MR Schneider","year":"2023","unstructured":"Schneider, M. R., Zettler, S., Rathkolb, B. & Dahlhoff, M. TXNIP overexpression in mice enhances streptozotocin-induced diabetes severity. Mol. Cell Endocrinol. 565, 111885 (2023).","journal-title":"Mol. Cell Endocrinol."}],"updated-by":[{"DOI":"10.1038\/s12276-025-01541-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000}}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01518-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01518-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01518-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T08:03:09Z","timestamp":1757059389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01518-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01518-w","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Author name Sungsoon Fang has been corrected. In this article the author\u2019s name Sungsoon Fang was incorrectly written as Sung Soon Fang. The original article has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s12276-025-01541-x","URL":"https:\/\/doi.org\/10.1038\/s12276-025-01541-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments followed the animal ethics guidelines and were approved by the Yonsei University Institutional Animal Care and Use Committee, Yonsei University School of Medicine (Seoul, Korea). All animal handling procedures adhered to the guidelines established by Association for Assessment and Accreditation of Laboratory Animal Care International and were approved by Yonsei University Institutional Animal Care and Use Committee (permit no. 2022-0240).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}